DD297841A5 - Herstellung von superoxiddismutase in pichia pastoris hefezellen - Google Patents

Herstellung von superoxiddismutase in pichia pastoris hefezellen Download PDF

Info

Publication number: DD297841A5
Authority: DD; German Democratic Republic
Prior art keywords: pastoris; gene; hsod; dna fragment; sod
Prior art date: 1989-02-13

Application number

DD33779190A

Other languages

German (de)

English (en)

Inventor

Willi Am S Craig

Gregory C Holtz

Geneva R Davis

Original Assignee

The Salk Institute Biotechnology/Industrial Associates,Us

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-13

Filing date

1990-02-12

Publication date

1992-01-23

1990-02-12 Application filed by The Salk Institute Biotechnology/Industrial Associates,Us filed Critical The Salk Institute Biotechnology/Industrial Associates,Us

1992-01-23 Publication of DD297841A5 publication Critical patent/DD297841A5/de

Links

241000235058 Komagataella pastoris Species 0.000 title claims abstract description 132
238000002360 preparation method Methods 0.000 title claims abstract description 10
OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 title description 15
230000014509 gene expression Effects 0.000 claims abstract description 67
238000000034 method Methods 0.000 claims abstract description 44
102000019197 Superoxide Dismutase Human genes 0.000 claims abstract description 26
108010012715 Superoxide dismutase Proteins 0.000 claims abstract description 26
230000008569 process Effects 0.000 claims abstract description 5
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 207
108090000623 proteins and genes Proteins 0.000 claims description 104
101150017120 sod gene Proteins 0.000 claims description 75
239000013612 plasmid Substances 0.000 claims description 71
239000012634 fragment Substances 0.000 claims description 65
108020004414 DNA Proteins 0.000 claims description 47
230000000694 effects Effects 0.000 claims description 47
229920001184 polypeptide Polymers 0.000 claims description 39
102000004196 processed proteins & peptides Human genes 0.000 claims description 39
108090000765 processed proteins & peptides Proteins 0.000 claims description 39
102100036826 Aldehyde oxidase Human genes 0.000 claims description 29
101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 claims description 29
108091028043 Nucleic acid sequence Proteins 0.000 claims description 25
230000035897 transcription Effects 0.000 claims description 21
238000013518 transcription Methods 0.000 claims description 21
108700039691 Genetic Promoter Regions Proteins 0.000 claims description 20
101150069554 HIS4 gene Proteins 0.000 claims description 20
239000013604 expression vector Substances 0.000 claims description 14
101710194180 Alcohol oxidase 1 Proteins 0.000 claims description 12
230000010354 integration Effects 0.000 claims description 12
230000033228 biological regulation Effects 0.000 claims description 11
239000003550 marker Substances 0.000 claims description 11
229910052799 carbon Inorganic materials 0.000 claims description 8
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
241000894006 Bacteria Species 0.000 claims description 6
230000009466 transformation Effects 0.000 claims description 6
238000006467 substitution reaction Methods 0.000 claims description 5
108700026220 vif Genes Proteins 0.000 claims description 5
230000010076 replication Effects 0.000 claims description 4
230000002103 transcriptional effect Effects 0.000 claims description 4
230000001939 inductive effect Effects 0.000 claims description 3
238000003306 harvesting Methods 0.000 claims description 2
102000004190 Enzymes Human genes 0.000 abstract description 16
108090000790 Enzymes Proteins 0.000 abstract description 16
238000004519 manufacturing process Methods 0.000 abstract description 16
101150061183 AOX1 gene Proteins 0.000 abstract description 13
239000000203 mixture Substances 0.000 abstract description 9
238000009395 breeding Methods 0.000 abstract 1
230000001488 breeding effect Effects 0.000 abstract 1
238000012258 culturing Methods 0.000 abstract 1
210000004027 cell Anatomy 0.000 description 60
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 48
240000004808 Saccharomyces cerevisiae Species 0.000 description 24
235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 24
238000002474 experimental method Methods 0.000 description 23
102000004169 proteins and genes Human genes 0.000 description 21
235000018102 proteins Nutrition 0.000 description 20
238000000855 fermentation Methods 0.000 description 17
230000004151 fermentation Effects 0.000 description 17
150000001413 amino acids Chemical group 0.000 description 16
230000012010 growth Effects 0.000 description 15
239000000499 gel Substances 0.000 description 14
238000004458 analytical method Methods 0.000 description 13
239000006166 lysate Substances 0.000 description 13
239000000126 substance Substances 0.000 description 12
108020004999 messenger RNA Proteins 0.000 description 11
239000000047 product Substances 0.000 description 11
239000010949 copper Substances 0.000 description 10
108010025188 Alcohol oxidase Proteins 0.000 description 9
IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 9
108091034117 Oligonucleotide Proteins 0.000 description 9
241000235648 Pichia Species 0.000 description 9
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
229960000723 ampicillin Drugs 0.000 description 9
239000000243 solution Substances 0.000 description 9
239000000758 substrate Substances 0.000 description 9
239000013598 vector Substances 0.000 description 9
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
229940024606 amino acid Drugs 0.000 description 8
235000001014 amino acid Nutrition 0.000 description 8
JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 8
239000011701 zinc Substances 0.000 description 8
102000003960 Ligases Human genes 0.000 description 7
108090000364 Ligases Proteins 0.000 description 7
238000005516 engineering process Methods 0.000 description 7
230000001965 increasing effect Effects 0.000 description 7
230000000644 propagated effect Effects 0.000 description 7
238000012216 screening Methods 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 6
241001288713 Escherichia coli MC1061 Species 0.000 description 6
230000001105 regulatory effect Effects 0.000 description 6
150000003839 salts Chemical class 0.000 description 6
230000005030 transcription termination Effects 0.000 description 6
108020004635 Complementary DNA Proteins 0.000 description 5
108020004511 Recombinant DNA Proteins 0.000 description 5
238000002105 Southern blotting Methods 0.000 description 5
239000007853 buffer solution Substances 0.000 description 5
238000010804 cDNA synthesis Methods 0.000 description 5
239000002299 complementary DNA Substances 0.000 description 5
210000003743 erythrocyte Anatomy 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
108020004707 nucleic acids Proteins 0.000 description 5
102000039446 nucleic acids Human genes 0.000 description 5
150000007523 nucleic acids Chemical class 0.000 description 5
238000012163 sequencing technique Methods 0.000 description 5
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 4
241000283690 Bos taurus Species 0.000 description 4
108010052832 Cytochromes Proteins 0.000 description 4
102000018832 Cytochromes Human genes 0.000 description 4
108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 4
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 4
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
238000011161 development Methods 0.000 description 4
230000018109 developmental process Effects 0.000 description 4
230000029087 digestion Effects 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
229910052757 nitrogen Inorganic materials 0.000 description 4
239000012071 phase Substances 0.000 description 4
238000000926 separation method Methods 0.000 description 4
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 4
238000011144 upstream manufacturing Methods 0.000 description 4
MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 3
238000000636 Northern blotting Methods 0.000 description 3
KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
102100033220 Xanthine oxidase Human genes 0.000 description 3
108010093894 Xanthine oxidase Proteins 0.000 description 3
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
238000010276 construction Methods 0.000 description 3
229910052802 copper Inorganic materials 0.000 description 3
230000006378 damage Effects 0.000 description 3
238000001514 detection method Methods 0.000 description 3
239000000284 extract Substances 0.000 description 3
230000006698 induction Effects 0.000 description 3
XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
229960004452 methionine Drugs 0.000 description 3
239000000178 monomer Substances 0.000 description 3
238000002703 mutagenesis Methods 0.000 description 3
231100000350 mutagenesis Toxicity 0.000 description 3
230000003647 oxidation Effects 0.000 description 3
238000007254 oxidation reaction Methods 0.000 description 3
239000008188 pellet Substances 0.000 description 3
230000008488 polyadenylation Effects 0.000 description 3
NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
239000008057 potassium phosphate buffer Substances 0.000 description 3
229960002477 riboflavin Drugs 0.000 description 3
235000019192 riboflavin Nutrition 0.000 description 3
239000002151 riboflavin Substances 0.000 description 3
239000000523 sample Substances 0.000 description 3
230000001225 therapeutic effect Effects 0.000 description 3
230000001131 transforming effect Effects 0.000 description 3
238000013519 translation Methods 0.000 description 3
238000001262 western blot Methods 0.000 description 3
229910052725 zinc Inorganic materials 0.000 description 3
101150005709 ARG4 gene Proteins 0.000 description 2
101710194173 Alcohol oxidase 2 Proteins 0.000 description 2
241000222120 Candida <Saccharomycetales> Species 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108091026890 Coding region Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
241001465754 Metazoa Species 0.000 description 2
108020005187 Oligonucleotide Probes Proteins 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 2
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 2
239000011543 agarose gel Substances 0.000 description 2
230000003698 anagen phase Effects 0.000 description 2
230000003110 anti-inflammatory effect Effects 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
239000011324 bead Substances 0.000 description 2
229960002685 biotin Drugs 0.000 description 2
235000020958 biotin Nutrition 0.000 description 2
239000011616 biotin Substances 0.000 description 2
OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000012512 characterization method Methods 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 2
239000013068 control sample Substances 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
239000013613 expression plasmid Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
239000011521 glass Substances 0.000 description 2
238000009396 hybridization Methods 0.000 description 2
239000003999 initiator Substances 0.000 description 2
229940099596 manganese sulfate Drugs 0.000 description 2
239000011702 manganese sulphate Substances 0.000 description 2
235000007079 manganese sulphate Nutrition 0.000 description 2
SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
238000010369 molecular cloning Methods 0.000 description 2
239000002751 oligonucleotide probe Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
229910000160 potassium phosphate Inorganic materials 0.000 description 2
235000011009 potassium phosphates Nutrition 0.000 description 2
230000003389 potentiating effect Effects 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
150000003254 radicals Chemical class 0.000 description 2
230000009467 reduction Effects 0.000 description 2
125000001452 riboflavin group Chemical group 0.000 description 2
239000012064 sodium phosphate buffer Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
-1 superoxide radicals Chemical class 0.000 description 2
239000012808 vapor phase Substances 0.000 description 2
230000009614 wildtype growth Effects 0.000 description 2
229940075420 xanthine Drugs 0.000 description 2
210000005253 yeast cell Anatomy 0.000 description 2
NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
101100098985 Caenorhabditis elegans cct-3 gene Proteins 0.000 description 1
241000283707 Capra Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
238000011537 Coomassie blue staining Methods 0.000 description 1
108010075031 Cytochromes c Proteins 0.000 description 1
CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
238000012270 DNA recombination Methods 0.000 description 1
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108010042407 Endonucleases Proteins 0.000 description 1
102000004533 Endonucleases Human genes 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
108010058643 Fungal Proteins Proteins 0.000 description 1
230000005526 G1 to G0 transition Effects 0.000 description 1
108700007698 Genetic Terminator Regions Proteins 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
241000700721 Hepatitis B virus Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
235000019766 L-Lysine Nutrition 0.000 description 1
FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
229930064664 L-arginine Natural products 0.000 description 1
235000014852 L-arginine Nutrition 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
239000004201 L-cysteine Substances 0.000 description 1
235000013878 L-cysteine Nutrition 0.000 description 1
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
229930182844 L-isoleucine Natural products 0.000 description 1
239000004395 L-leucine Substances 0.000 description 1
235000019454 L-leucine Nutrition 0.000 description 1
229930195722 L-methionine Natural products 0.000 description 1
229930182821 L-proline Natural products 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
208000037273 Pathologic Processes Diseases 0.000 description 1
102000035195 Peptidases Human genes 0.000 description 1
108091005804 Peptidases Proteins 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
241000493790 Photobacterium leiognathi Species 0.000 description 1
239000004365 Protease Substances 0.000 description 1
108020005091 Replication Origin Proteins 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
244000300264 Spinacia oleracea Species 0.000 description 1
235000009337 Spinacia oleracea Nutrition 0.000 description 1
241000255588 Tephritidae Species 0.000 description 1
108020005038 Terminator Codon Proteins 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
108700009124 Transcription Initiation Site Proteins 0.000 description 1
108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
241000269959 Xiphias gladius Species 0.000 description 1
PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
239000000370 acceptor Substances 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
229960003767 alanine Drugs 0.000 description 1
125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
150000001447 alkali salts Chemical class 0.000 description 1
150000001450 anions Chemical class 0.000 description 1
239000002518 antifoaming agent Substances 0.000 description 1
101150031623 aox gene Proteins 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
229960005261 aspartic acid Drugs 0.000 description 1
238000003556 assay Methods 0.000 description 1
230000002567 autonomic effect Effects 0.000 description 1
238000011021 bench scale process Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
238000004166 bioassay Methods 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
150000001721 carbon Chemical class 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000002759 chromosomal effect Effects 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
210000001072 colon Anatomy 0.000 description 1
239000000306 component Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
238000012937 correction Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
229940111685 dibasic potassium phosphate Drugs 0.000 description 1
239000000539 dimer Substances 0.000 description 1
229910001882 dioxygen Inorganic materials 0.000 description 1
ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000006167 equilibration buffer Substances 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000012246 gene addition Methods 0.000 description 1
238000007429 general method Methods 0.000 description 1
229960002989 glutamic acid Drugs 0.000 description 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
230000036541 health Effects 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
239000000833 heterodimer Substances 0.000 description 1
229960002885 histidine Drugs 0.000 description 1
238000011905 homologation Methods 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000028709 inflammatory response Effects 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000003834 intracellular effect Effects 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
238000009533 lab test Methods 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
229960003136 leucine Drugs 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229910052943 magnesium sulfate Inorganic materials 0.000 description 1
235000019341 magnesium sulphate Nutrition 0.000 description 1
210000004962 mammalian cell Anatomy 0.000 description 1
239000011572 manganese Substances 0.000 description 1
235000019988 mead Nutrition 0.000 description 1
239000012533 medium component Substances 0.000 description 1
230000037353 metabolic pathway Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000035772 mutation Effects 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
239000013631 noncovalent dimer Substances 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000009054 pathological process Effects 0.000 description 1
210000001539 phagocyte Anatomy 0.000 description 1
229960005190 phenylalanine Drugs 0.000 description 1
230000027086 plasmid maintenance Effects 0.000 description 1
OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
229910052939 potassium sulfate Inorganic materials 0.000 description 1
239000001120 potassium sulphate Substances 0.000 description 1
235000011151 potassium sulphates Nutrition 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
238000004321 preservation Methods 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
229960002429 proline Drugs 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
230000000754 repressing effect Effects 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
238000007480 sanger sequencing Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000011218 seed culture Methods 0.000 description 1
229960001153 serine Drugs 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
241000894007 species Species 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
230000007480 spreading Effects 0.000 description 1
238000003892 spreading Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
235000021335 sword fish Nutrition 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
201000004415 tendinitis Diseases 0.000 description 1
229960002898 threonine Drugs 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
238000002054 transplantation Methods 0.000 description 1
229960004799 tryptophan Drugs 0.000 description 1
102000003390 tumor necrosis factor Human genes 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
229960001763 zinc sulfate Drugs 0.000 description 1
229910000368 zinc sulfate Inorganic materials 0.000 description 1
239000011686 zinc sulphate Substances 0.000 description 1
235000009529 zinc sulphate Nutrition 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2462—Lysozyme (3.2.1.17)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Mycology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Enzymes And Modification Thereof (AREA)

DD33779190A 1989-02-13 1990-02-12 Herstellung von superoxiddismutase in pichia pastoris hefezellen DD297841A5 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US31151789A	1989-02-13	1989-02-13

Publications (1)

Publication Number	Publication Date
DD297841A5 true DD297841A5 (de)	1992-01-23

Family

ID=23207267

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DD33779190A DD297841A5 (de)	1989-02-13	1990-02-12	Herstellung von superoxiddismutase in pichia pastoris hefezellen

Country Status (6)

Country	Link
EP (1)	EP0388008A1 (sh)
AU (1)	AU5196290A (sh)
DD (1)	DD297841A5 (sh)
PT (1)	PT93135A (sh)
WO (1)	WO1990009434A1 (sh)
YU (1)	YU28490A (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5612198A (en) *	1990-09-04	1997-03-18	The Salk Institute	Production of insulin-like growth factor-1 in methylotrophic yeast cells
WO1992013951A1 (en) *	1991-02-04	1992-08-20	The Salk Institute Biotechnology/Industrial Associates, Inc.	Production of human serum albumin in methylotrophic yeast cells
DE69232666T2 (de) *	1991-04-01	2003-03-20	Merck & Co., Inc.	Gene, die die proteolytische aktivitaet von pichia beeinflussen und deren verwendung
CN108165567A (zh) *	2017-12-19	2018-06-15	佛山科学技术学院	人溶菌酶基因的合成及其表达产物的构建方法
CN116004557A (zh) *	2022-11-28	2023-04-25	西安德诺海思医疗科技有限公司	重组超氧化物歧化酶的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0656418B1 (en) *	1983-10-03	2002-12-04	Chiron Corporation	Superoxide dismutase and expression in microorganisms
US4855231A (en) *	1984-10-30	1989-08-08	Phillips Petroleum Company	Regulatory region for heterologous gene expression in yeast
US4885242A (en) *	1984-10-30	1989-12-05	Phillips Petroleum Company	Genes from pichia histidine pathway and uses thereof
US4879231A (en) *	1984-10-30	1989-11-07	Phillips Petroleum Company	Transformation of yeasts of the genus pichia
US4882279A (en) *	1985-10-25	1989-11-21	Phillips Petroleum Company	Site selective genomic modification of yeast of the genus pichia
US4895800A (en) *	1985-11-26	1990-01-23	Phillips Petroleum Company	Yeast production of hepatitis B surface antigen
IL82935A0 (en) *	1986-08-12	1987-12-20	Phillips Petroleum Co	Secretion of heterologous proteins from yeast
ATE72581T1 (de) *	1987-03-16	1992-02-15	Chiron Corp	Superoxiddismutase-polymere.
US4885231A (en) *	1988-05-06	1989-12-05	Bell Communications Research, Inc.	Phase-shifted gratings by selective image reversal of photoresist

1990
- 1990-02-12 AU AU51962/90A patent/AU5196290A/en not_active Abandoned
- 1990-02-12 DD DD33779190A patent/DD297841A5/de not_active IP Right Cessation
- 1990-02-12 WO PCT/US1990/000781 patent/WO1990009434A1/en unknown
- 1990-02-13 YU YU28490A patent/YU28490A/sh unknown
- 1990-02-13 PT PT9313590A patent/PT93135A/pt not_active Application Discontinuation
- 1990-02-13 EP EP90301495A patent/EP0388008A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
AU5196290A (en)	1990-09-05
YU28490A (sh)	1992-09-07
WO1990009434A1 (en)	1990-08-23
EP0388008A1 (en)	1990-09-19
PT93135A (pt)	1990-08-31

Publication	Publication Date	Title
DE3280479T2 (de)	1999-03-11	Rekombinante DNS-Mittel und Verfahren
DE3786767T3 (de)	1998-04-16	Neues Polypeptid.
DE68929115T2 (de)	2000-06-15	Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe
DE69325794T2 (de)	2000-01-13	Humanes serum albumin, herstellung und verwendung
DE3280422T2 (de)	1993-05-27	Verfahren und produkte zur leichten mikrobiologischen expression von dns-sequenzen.
DE69228497T2 (de)	1999-07-15	Expression von menschlichen Serum-Albuminen in Pichia Pastoris
DE69937243T2 (de)	2008-07-03	Überexpression von gewünschten proteinen in eukaryotischen zellen mittels überexpression von cyclin d1
DE3486452T2 (de)	1997-11-06	Superoxiddismutase und deren Expression in Mikroorganismen
DE3650749T2 (de)	2001-04-05	DNA Fragment kodierend für eine AOX
EP0387527B1 (de)	1994-06-22	Verfahren zur fermentativen Herstellung von L-Lysin
DD212982A5 (de)	1984-08-29	Verfahren zur herstellung von rinder-wachstumshormon-aehnlichen polypeptiden
JPH04501662A (ja)	1992-03-26	混合給送組換え酵母発酵
DE3852706T2 (de)	1995-05-24	Verfahren zur Herstellung eines physiologisch aktiven Peptids mit einem Cysteinrest.
CH663032A5 (de)	1987-11-13	Doppelstraengige dna, replizierbare plasmidische expressionstraeger zur mikrobiellen herstellung von hybrid human-leukozyten-interferon und transformierte mikroorganismen.
DD284047A5 (de)	1990-10-31	Verfahren zur herstellung einer dna-sequenz, die fuer einen alkohol-oxidose-ii-regulationsbereich einer methylotrophen hefe kodiert
DD219505A5 (de)	1985-03-06	Verfahren zur herstellung von schweine-wachstumshormonaehnlichen polypeptiden
EP0373597B1 (de)	1993-09-29	Gen und Genstruktur, codierend für eine Aminotransferase, und Mikroorganismen, die dieses Gen exprimieren
AT389892B (de)	1990-02-12	Dna-sequenz mit einem gen, das fuer human-interleukin-2 codiert
DE69027948T2 (de)	1997-01-30	Reinigung von rekombinantem, menschlichem Interleukin-3
DE69233031T2 (de)	2003-12-24	Hefepromotor und seine verwendung
DE3689899T2 (de)	1994-09-15	Verfahren und hybridpromotor zur steuerung der exogenen gentranskription.
DD297841A5 (de)	1992-01-23	Herstellung von superoxiddismutase in pichia pastoris hefezellen
DE3782560T2 (de)	1993-06-03	Hefestaemme zur expression fremder gene.
DE3687470T2 (de)	1993-05-19	Expression in e.coli von hybridpolypeptiden, die die sequenz des wachstumshormons ausloesenden faktors enthalten.
DE3586830T2 (de)	1993-04-22	Verfahren zur ligation von heterogenen genen.

Legal Events

Date	Code	Title	Description
1995-05-11	ENJ	Ceased due to non-payment of renewal fee